MCAG Mountain Crest Acquisition Corp. V
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1859035 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY79.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-9.6%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets414.1%
Debt / equity—
Current ratio0.05x
Interest coverage—
Cash quality & payout
Operating cash flow / net income5.57x
Accruals ratio43.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| SG&A expense | $471,782 | $618,486 |
| Operating income | -$471,782 | -$618,486 |
| Interest expense | — | $1,402 |
| Pretax income | -$422,267 | -$328,558 |
| Income tax | $8,894 | $45,896 |
| Net income | -$431,161 | -$374,454 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $11,909 | $116,658 |
| Current assets | $32,927 | $156,779 |
| Total assets | $873,566 | $1.31M |
| Current liabilities | $1.65M | $1.52M |
| Total liabilities | $3.72M | $3.59M |
| Shareholders' equity | -$3.68M | -$3.44M |
| Shares outstanding | 2.80M | 2.80M |
| Cash flow statement | ||
| Operating cash flow | -$741,998 | -$921,200 |
| Investing cash flow | $362,787 | $4.72M |
| Financing cash flow | $274,462 | -$3.70M |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.